Citigroup
EVH icon

Citigroup’s Evolent Health EVH Stock Holding History

Citigroup’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-71,800
Closed -$2.03M – 5870
2024
Q3 		$2.03M Buy
+71,800
New +$1.85M ﹤0.01% 2654
2021
Q4 		– Sell
-50,000
Closed -$1.55M – 5897
2021
Q3 		$1.55M Buy
+50,000
New +$1.2M ﹤0.01% 2741

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup's EVH Position: Q1 2026 in Review

Citigroup increased its Evolent Health (EVH) stake by 39% in Q1 2026, buying an estimated $722K and bringing the position to 812,095 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2713.

Citigroup first reported a position in EVH in Q2 2015 and has held it in 44 quarters since. The position peaked at $9.18M in Q2 2019. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Citigroup held 812,095 shares of Evolent Health worth $1.85M as of Q1 2026.
  • Citigroup bought 227,630 Evolent Health shares in Q1 2026, an estimated $722K.
  • Evolent Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2713 holding.
  • Citigroup first reported a position in Evolent Health in Q2 2015 and has held it in 44 quarters since.
  • Citigroup's Evolent Health position peaked at $9.18M in Q2 2019.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.